Pileri S.; Agostinelli C.; Campidelli C.; Righi S.; Piccioli M.; Bacci F.; Sabattini E.; Zinzani P.L.; Piccaluga P.P., Tissue micro-array in haematopathology:present usage and potential., in: Abstract Book, «HAEMATOLOGICA», 2006, 91(s3), pp. 9 - 10 (atti di: IX Congress of the Italian Society of Experimental Hematology. Naples,, Naples, Italia, September 20-22, 2006.) [Contribution to conference proceedings]
PICCALUGA PP; MARTINELLI G; MALAGOLA M; RONDONI M; BONIFAZI F; BANDINI G; VISANI G; BACCARANI M., Alemtuzumab in the treatment of relapsed acute lymphoid leukaemia., «LEUKEMIA», 2005, 19, pp. 135 - 136 [Scientific article]
Visani G; Guiducci B; D'Adamo F; Mele A; Nicolini G; Leopardi G; Sparaventi G; Barulli S; Malerba L; Isidori A; Malagola M; Piccaluga PP., Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma., «LEUKEMIA & LYMPHOMA», 2005, 46, pp. 477 - 479 [Scientific article]
Piccaluga PP; Agostinelli C; Zinzani PL; Baccarani M; Dalla Favera R; Pileri SA., Expression of platelet-derived growth factor receptor alpha in peripheral T-cell lymphoma not otherwise specified, «THE LANCET ONCOLOGY», 2005, 6 (6), pp. 440 - 440 [Scientific article]
Piccaluga PP; Vigna E; Martinelli G., Fattibilità ed efficacia del regime chemioterapico My-Flaig (mylotarg, fludarabina, citosina arabinsoide, idarubicina e pegfilgrastim) nella terapia della leucemia acuta mieloide., «CONTINUING EDUCATION IN ONCOLOGIA», 2005, 2, pp. 8 - 11 [Scientific article]
Piccaluga P.P.; Agostinelli C.; Zupo S.; Califano A.; Went P.; Ascani S.; Basso K.; Facchetti F.; Falini B.; Ferrarini M.; Gallamini A.; Klein U.; Novero D.; Paulli M.; Tura S.; Zinzani PL.; Baccarani M.; Dalla-Favera R.; Pileri SA., Gene Expression analysis of Peripheral T-Cell Lympoma Not Otherwise Specified Reveals the Existance of Two Subgroups Related to Different Celular Counterparts and Recurrent PDGFRA Deregulation., in: American Society of Hematology 47th Meeting and Exposition.December 10-13,Atlanta, Georgia, US, «BLOOD», 2005, 106, pp. 354a - 354a (atti di: American Society of Hematology 47th Meeting and Exposition., Atlanta, Georgia, US, December 10-13,) [Abstract]
ZINZANI P.; DIRNHOFER S; SABATTINI E; ALINARI L; PICCALUGA PP; STEFONI V; TANI M; MUSURACA G; MARCHI E; FALINI B; BACCARANI M; PILERI SA., Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays., «HAEMATOLOGICA», 2005, 90, pp. 341 - 347 [Scientific article]
Malagola M; Martinelli G; Rondoni M; Paolini S; Gaitani S; Arpinati M; Piccaluga PP; Amabile M; Basi C; Ottaviani E; Candoni A; Gottardi E; Cilloni D; Bocchia M; Saglio G; Lauria F; Fanin R; Visani G; Marre MC; Maderna M; Rancati F; Vinaccia V; Russo D; Baccarani M., Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target?, «BLOOD», 2005, 105(2), pp. 904 - 904 [Scientific article]
Vigna E; Placci A; Laterza C; Agostinelli C; Papayannidis C; Martinelli G; Pileri SA; Piccaluga PP., Impiego del pegfilgrastim in associazione cn R-CHOP in un paziente critico affetto da un linfoma non Hodgkin aggressivo primitivo del cuore., «CONTINUING EDUCATION IN ONCOLOGIA», 2005, 2, pp. 5 - 7 [Scientific article]
Piccaluga PP.; Went P.; Agostinelli C.; Gallamini A.; Ascani S.; Sabattini E.; Bacci F.; Falini B.; Motta T.; Paulli M.; Artusi T.; Zinzani PL.; Baccarani M.; Pileri SA., Marker expression in Peripheral T-Cell Lymphoma Unspecified: Proposal of a Clinical-Pathologic Prognostic Score., in: American Society of Hematology 47th Meeting and Exposition,Decembe,Atlanta, Georgia, USr, «BLOOD», 2005, 106, pp. 790a - 790a (atti di: American Society of Hematology 47th Meeting and Exposition., Atlanta, Georgia, US, December 10-13, 2005) [Abstract]
Mele A; Leopardi G; Sparaventi G; Nicolini G; D'Adamo F; Guiducci B; Barulli S; Malerba L; Stramigioli S; Talevi N; Politi P; Isidori A; Malagola M; Piccaluga P; Visani G., Mini-ICE effectively mobilises peripheral blood stem cells after
fludarabine-based regimens in acute myeloid leukaemia., «EUROPEAN JOURNAL OF HAEMATOLOGY», 2005, 74, pp. 277 - 281 [Scientific article]
Russo D; Malagola M; Vivo A; Fiacchini M; Martinelli G; Piccaluga PP; Damiani D; Candoni A; Michielutti A; Castelli M; Testoni N; Ottaviani E; Rondoni M; Pricolo G; Mazza P; Zuffa E; Zaccaria A; Raspadori D; Bocchia M; Lauria F; Bonini A; Avanzini P; Gugliotta L; Visani G; Fanin R; Baccarani M, Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients, «BRITISH JOURNAL OF HAEMATOLOGY», 2005, 131(2), pp. 172 - 179 [Scientific article]
Martinelli G; Malagola M; Rondoni M; Piccaluga PP; Bosi C; Russo D; Baccarani M., Strategies in the treatment of acute myeloid leukemia., in: Libro degli Atti, Diagnosi e terapia molecolare delle neoplasie ematologiche., S.N., s.n, 2005, pp. 58 - 69 [Chapter or essay]
Pileri S.A.; Piccaluga P.P.; Sabattini E.; Zinzani P.L., The development of more than one histologic type of lymphoma in the same patient is frequent and confers a worse prognosis, «HAEMATOLOGICA», 2005, 90(3), pp. 293 - 293 [Scientific article]Open Access
van der Holt B; Lowenberg B; Burnett AK; Knauf WU; Shepherd J; Piccaluga PP; Ossenkoppele GJ; Verhoef GE; Ferrant A; Crump M; Selleslag D; Theobald M; Fey MF; Vellenga E; Dugan M; Sonneveld P., The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and
cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis., «BLOOD», 2005, 106, pp. 2646 - 2654 [Scientific article]
